Immunogenicity and safety of WHO-approved TRC-ID regimen with a chromatographically purified Vero cell rabies vaccine with or without rabies immunoglobulin in children

• Main Authors: Piyada Angsuwatcharakon (Author), Sumana Khomvilai (Author), Kornvika Limsuwun (Author), Natchaya Ratananpinit (Author), Apinya Khamchat (Author), Teeranit Sanitnai (Author), Terapong Tantawichien (Author)
• Format: Book
• Published: Taylor & Francis Group, 2018-02-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Introduction: Children are at risk of rabies exposure in many Asian countries. The safety and immunogenicity profile of the WHO-approved two-site intradermal Thai Red Cross regimen (modified TRC-ID regimen; 2-2-2-0-2) with a new chromatographically purified Vero-cell rabies vaccine (CPRV) is lacking...